Device / Technology News

RSS

Over 125,000 NYU Langone patients now use new biometric identification system

Launched just nine months ago, more than 125,000 patients at NYU Langone Medical Center are now using PatientSecure, a cutting-edge biometric identification system.

13 Mar 2012

Lowering HbA1c cutoffs increases health benefits of type 2 diabetes preventive interventions

The American Diabetes Association recommends hemoglobin A1c (HbA1c) testing as one basis for identifying diabetes and prediabetes.

13 Mar 2012

Some adaptive motion trainers may still impose high stresses on the knee

New research conducted by the University of Wisconsin - La Crosse Department of Physical Therapy calls into question the conventional wisdom that non-impact cardio machines, such as adaptive motion trainers (AMTs), apply minimum stress to the joints.

13 Mar 2012

Researchers identify variation in head CT use among ED doctors

A new study by Brigham and Women's Hospital (BWH) researchers found significant variation in the use of head computed tomography (CT) exams among doctors within the emergency department.

13 Mar 2012

Thermo Fisher launches three new capillary ion chromatography columns

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced three new high-capacity, high-efficiency 4 µm particle-size capillary IC columns that enable faster, more accurate analyses.

From Thermo Fisher Scientific Inc. 13 Mar 2012

Study reveals significant variation in use of head computed tomography

Imaging has been identified as one of the key drivers of increased healthcare costs. A new study from Brigham and Women's Hospital and Harvard Medical School has found significant variation in the use of head computed tomography (CT), even within a single emergency department. Strategies to reduce such variation in head CT use may reduce cost and improve quality of care.

12 Mar 2012

Majority of physicians utilize genetic testing, finds report

A new report by UnitedHealth Group's Center for Health Reform & Modernization finds that a majority of physicians are utilizing genetic testing. The report, titled "Personalized Medicine: Trends and prospects for the new science of genetic testing and molecular diagnostics," presents new findings on how genetic tests can help diagnose disease, target prevention, and ensure that patients receive the medicines that will best treat their conditions.

12 Mar 2012

AB SCIEX introduces new triple quadrupole mass spectrometry instrumentation system

AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.

12 Mar 2012

UnitedHealth report: Spending on genetic tests to rise sharply in a decade

Genetic tests could become a $25 billion market by 2021. Currently, spending on these tests is estimated at $5 billion annually.

12 Mar 2012

Simple device for disinfecting stethoscopes

According to the Centers for Disease Control and Prevention (CDC) 1,900,000 people contract infections in hospitals, (Hospital Acquired Infections - HAIs) every year and well over 99,000 die as a result; more deaths than from AIDS, breast cancer and auto accidents combined.

12 Mar 2012

Thermo Fisher Scientific introduces integrated capillary high-pressure ion chromatography system

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Thermo Scientific Dionex ICS-4000, the world's first commercially available integrated capillary high-pressure ion chromatography (HPIC) system, incorporating multiple detector options in one instrument.

From Thermo Fisher Scientific Inc. 12 Mar 2012

LensAR closes $24 million private financing

LensAR Inc., a developer of the next generation of laser systems for cataract surgery, announced the closing of a $24 million private financing which included investments from Aisling Capital and Florida Growth Fund (FGF).

12 Mar 2012

Thermo Fisher Scientific launches Acclaim Surfactant Plus and MAbPac SCX-10 chromatography columns

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new chromatography columns, the Thermo Scientific Acclaim Surfactant Plus and smaller-particle sized Thermo Scientific MAbPac SCX-10.

From Thermo Fisher Scientific Inc. 12 Mar 2012

Thermo Fisher Scientific introduces new ICP-MS system, iCAP Q

Thermo Fisher Scientific Inc., the world leader in serving science, today launched its new Thermo Scientific iCAP Q, an ICP-MS system that features world-class performance and increased throughput to help laboratories cut analysis times by up to 50 percent when compared to the XSERIES 2 ICP-MS, the model it replaces.

From Thermo Fisher Scientific Inc. 12 Mar 2012

Korean FDA grants pre-market clearance for ETView's VivaSight‐SL airway management solutions

ETView today announced that the Korean Food and Drug Administration ("KFDA") has granted pre-market clearance for VivaSight‐SL. With KFDA clearance, ETView plans to immediately initiate market launch of VivaSight‐SL. ETView also announced a distribution agreement with ChinooMTech Company.

12 Mar 2012

Interventional Spine's PerX360 System to be presented at ISASS annual meeting

Interventional Spine, Inc. today announced that Dr. Rudolf Morgenstern, Director and Chief Surgeon of the Morgenstern Institute for Endoscopic Spine Surgery at Centro Medico Teknon in Barcelona, and Dr. David Greenwald from Flagler Brain and Spine Institute of St. Augustine, Florida will present the PerX360 System at the International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting in Barcelona, Spain.

12 Mar 2012

InflammaGen to initiate Phase 2 study of new drug/delivery platform for shock

A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Sch-nbein. Conditions expected to qualify for the study include new-onset sepsis and septic shock, post-operative complications, and new-onset gastrointestinal bleeding.

12 Mar 2012

UHC retires negative coverage policy effective April 1, 2012

Aerocrine AB announces that United Healthcare has retired its negative coverage policy effective April 1, 2012.

12 Mar 2012

Cicel, Mazor Robotics sign agreement to distribute Renaissance system in China

Mazor Robotics Ltd, the leader in innovative surgical robots and complementary products for spine surgery, signed an agreement with Cicel Science & Technology Co., Ltd. to distribute its Renaissance system in China.

12 Mar 2012

Chlamydia has evolved more actively than previously thought

In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought. Using whole genome sequencing the researchers show that the exchange of DNA between different strains of Chlamydia to form new strains is much more common than expected.

12 Mar 2012